Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.

Kiani Z, Dupuy FP, Bruneau J, Lebouché B, Retière C, Geraghty DE, Bernard NF.

J Virol. 2019 Sep 11. pii: JVI.01185-19. doi: 10.1128/JVI.01185-19. [Epub ahead of print]

PMID:
31511383
2.

Plasma levels of C-type lectin REG3α and gut damage in people with HIV.

Isnard S, Ramendra R, Dupuy FP, Lin J, Fombuena B, Kokinov N, Kema I, Jenabian MA, Lebouché B, Costiniuk CT, Ancuta P, Bernard NF, Silverman MS, Lakatos PL, Durand M, Tremblay C, Routy JP; Montreal primary HIV infection study; Canadian cohort of HIV+ slow progressors; Canadian HIV and Aging cohort groups.

J Infect Dis. 2019 Aug 23. pii: jiz423. doi: 10.1093/infdis/jiz423. [Epub ahead of print]

PMID:
31504638
3.

HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1.

Kiani Z, Bruneau J, Geraghty DE, Bernard NF.

J Virol. 2019 Aug 28;93(18). pii: e00933-19. doi: 10.1128/JVI.00933-19. Print 2019 Sep 15.

PMID:
31270222
4.

Quantifying Anti-HIV Envelope-Specific Antibodies in Plasma from HIV Infected Individuals.

Kant S, Zhang N, Routy JP, Tremblay C, Thomas R, Szabo J, Côté P, Trottier B, LeBlanc R, Rouleau D, Harris M, Dupuy FP, Bernard NF.

Viruses. 2019 May 28;11(6). pii: E487. doi: 10.3390/v11060487.

5.

Circulating (1→3)-β-D-Glucan is associated with immune activation during HIV infection.

Mehraj V, Ramendra R, Isnard S, Dupuy FP, Ponte R, Chen J, Kema I, Jenabian MA, Costiniuk C, Lebouché B, Thomas R, Coté P, Leblanc R, Baril JG, Durand M, Chartrand-Lefebvre C, Tremblay C, Ancuta P, Bernard NF, Sheppard DC, Routy JP; Montreal Primary HIV-infection Study and Canadian HIV and Aging Cohort Study Groups.

Clin Infect Dis. 2019 Mar 16. pii: ciz212. doi: 10.1093/cid/ciz212. [Epub ahead of print]

PMID:
30877304
6.

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.

Lisovsky I, Kant S, Tremblay-McLean A, Isitman G, Kiani Z, Dupuy FP, Gilbert L, Bruneau J, Shoukry NH, Lebouché B, Bernard NF.

J Leukoc Biol. 2019 Mar;105(3):551-563. doi: 10.1002/JLB.4A0617-242RRR. Epub 2019 Jan 30.

PMID:
30698860
7.

Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function.

Tremblay-McLean A, Coenraads S, Kiani Z, Dupuy FP, Bernard NF.

BMC Immunol. 2019 Jan 29;20(1):8. doi: 10.1186/s12865-018-0272-x.

8.

HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1.

Kiani Z, Dupuy FP, Bruneau J, Lebouché B, Zhang CX, Jackson E, Lisovsky I, da Fonseca S, Geraghty DE, Bernard NF.

J Immunol. 2018 Jul 1;201(1):113-123. doi: 10.4049/jimmunol.1701370. Epub 2018 May 9.

9.

Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy.

Wang C, Edilova MI, Wagar LE, Mujib S, Singer M, Bernard NF, Croughs T, Lederman MM, Sereti I, Fischl MA, Kremmer E, Ostrowski M, Routy JP, Watts TH.

J Immunol. 2018 Jan 15;200(2):558-564. doi: 10.4049/jimmunol.1601254. Epub 2017 Dec 8.

10.

Characterization of myeloid cell populations in human testes collected after sex reassignment surgery.

Ponte R, Dupuy FP, Brimo F, Mehraj V, Brassard P, Belanger M, Yurchenko E, Jenabian MA, Bernard NF, Routy JP; ORCHID study group.

J Reprod Immunol. 2018 Feb;125:16-24. doi: 10.1016/j.jri.2017.10.043. Epub 2017 Oct 14.

PMID:
29136520
11.

Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.

Tremblay-McLean A, Bruneau J, Lebouché B, Lisovsky I, Song R, Bernard NF.

Viruses. 2017 Oct 12;9(10). pii: E295. doi: 10.3390/v9100295.

12.

HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness.

Jackson E, Zhang CX, Kiani Z, Lisovsky I, Tallon B, Del Corpo A, Gilbert L, Bruneau J, Thomas R, Côté P, Trottier B, LeBlanc R, Rouleau D, Tremblay C, Tsoukas CM, Routy JP, Ni X, Mabanga T, Bernard NF; Montreal Primary Infection Study Group.

PLoS One. 2017 Sep 22;12(9):e0185160. doi: 10.1371/journal.pone.0185160. eCollection 2017.

14.

Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.

Bernard NF, Kiani Z, Tremblay-McLean A, Kant SA, Leeks CE, Dupuy FP.

Front Immunol. 2017 Aug 24;8:1033. doi: 10.3389/fimmu.2017.01033. eCollection 2017. Review.

15.

Beyond Viral Neutralization.

Lewis GK, Pazgier M, Evans DT, Ferrari G, Bournazos S, Parsons MS, Bernard NF, Finzi A.

AIDS Res Hum Retroviruses. 2017 Aug;33(8):760-764. doi: 10.1089/AID.2016.0299. Epub 2017 Feb 16. Review.

16.

Novel E2 Glycoprotein Tetramer Detects Hepatitis C Virus-Specific Memory B Cells.

Boisvert M, Zhang W, Elrod EJ, Bernard NF, Villeneuve JP, Bruneau J, Marcotrigiano J, Shoukry NH, Grakoui A.

J Immunol. 2016 Dec 15;197(12):4848-4858. Epub 2016 Nov 14.

17.

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.

Isitman G, Tremblay-McLean A, Lisovsky I, Bruneau J, Lebouché B, Routy JP, Bernard NF.

PLoS One. 2016 Oct 12;11(10):e0164517. doi: 10.1371/journal.pone.0164517. eCollection 2016.

18.

The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection.

Lisovsky I, Isitman G, Tremblay-McLean A, Song R, DaFonseca S, Lebouchẻ B, Routy JP, Bruneau J, Bernard NF.

Clin Exp Immunol. 2016 Dec;186(3):336-346. doi: 10.1111/cei.12849. Epub 2016 Sep 9.

19.

Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.

Isitman G, Lisovsky I, Tremblay-McLean A, Kovacs C, Harris M, Routy JP, Bruneau J, Wainberg MA, Tremblay C, Bernard NF.

AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1079-1088. Epub 2016 Sep 7.

PMID:
27499379
20.

Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection.

Demers KR, Makedonas G, Buggert M, Eller MA, Ratcliffe SJ, Goonetilleke N, Li CK, Eller LA, Rono K, Maganga L, Nitayaphan S, Kibuuka H, Routy JP, Slifka MK, Haynes BF, McMichael AJ, Bernard NF, Robb ML, Betts MR.

PLoS Pathog. 2016 Aug 3;12(8):e1005805. doi: 10.1371/journal.ppat.1005805. eCollection 2016 Aug.

21.

Natural killer cell education does not affect the magnitude of granzyme B delivery to target cells by antibody-dependent cellular cytotoxicity.

Isitman G, Lisovsky I, Tremblay-McLean A, Parsons MS, Shoukry NH, Wainberg MA, Bruneau J, Bernard NF.

AIDS. 2015 Jul 31;29(12):1433-43. doi: 10.1097/QAD.0000000000000729.

PMID:
26244383
22.

A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.

Lisovsky I, Isitman G, Song R, DaFonseca S, Tremblay-McLean A, Lebouché B, Routy JP, Bruneau J, Bernard NF.

J Virol. 2015 Oct;89(19):9909-19. doi: 10.1128/JVI.01546-15. Epub 2015 Jul 22.

23.

Functional analysis of NK cell subsets activated by 721.221 and K562 HLA-null cells.

Lisovsky I, Isitman G, Bruneau J, Bernard NF.

J Leukoc Biol. 2015 Apr;97(4):761-7. doi: 10.1189/jlb.4AB1014-499R. Epub 2015 Feb 20.

PMID:
25713086
24.

Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.

Tang CC, Isitman G, Bruneau J, Tremblay C, Bernard NF, Kent SJ, Parsons MS.

Clin Exp Immunol. 2015 Aug;181(2):275-85. doi: 10.1111/cei.12593. Epub 2015 Jun 7.

25.

Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.

Tallon BJ, Bruneau J, Tsoukas CM, Routy JP, Kiani Z, Tan X, Bernard NF.

PLoS One. 2014 Oct 17;9(10):e110480. doi: 10.1371/journal.pone.0110480. eCollection 2014.

26.

HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.

Song R, Lisovsky I, Lebouché B, Routy JP, Bruneau J, Bernard NF.

PLoS Pathog. 2014 Jan;10(1):e1003867. doi: 10.1371/journal.ppat.1003867. Epub 2014 Jan 16.

27.

HIV-1 subtype variability in Vif derived from molecular clones affects APOBEC3G-mediated host restriction.

Lisovsky I, Schader SM, Sloan RD, Oliveira M, Coutsinos D, Bernard NF, Wainberg MA.

Intervirology. 2013;56(4):258-64. doi: 10.1159/000348513. Epub 2013 May 8.

28.

On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?

Parsons MS, Muller S, Kohler H, Grant MD, Bernard NF.

Hum Vaccin Immunother. 2013 Jul;9(7):1532-8. doi: 10.4161/hv.24460. Epub 2013 Apr 9. Review.

PMID:
23571168
29.

Short communication: antibody responses to human immunodeficiency virus envelope from infections with multiple subtypes utilize the 1F7-idiotypic repertoire.

Parsons MS, Center RJ, Routy JP, Rouleau D, Leblanc R, Wainberg MA, Tremblay CL, Zannou MD, Kent SJ, Grant MD, Bernard NF.

AIDS Res Hum Retroviruses. 2013 May;29(5):778-83. doi: 10.1089/AID.2012.0094. Epub 2013 Jan 29.

30.

Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides.

Doroudchi M, Yegorov O, Baumgartner T, Kernaleguen AE, Breton G, Ndongala ML, Boulassel MR, Routy JP, Bernard NF, Sékaly RP, Yassine-Diab B.

PLoS One. 2012;7(11):e49562. doi: 10.1371/journal.pone.0049562. Epub 2012 Nov 19.

31.

Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells.

Wren L, Parsons MS, Isitman G, Center RJ, Kelleher AD, Stratov I, Bernard NF, Kent SJ.

PLoS One. 2012;7(6):e38580. doi: 10.1371/journal.pone.0038580. Epub 2012 Jun 11.

32.

Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressors.

Kamya P, Tallon B, Melendez-Pena C, Parsons MS, Migueles SA, Connors M, Miconiatis S, Song R, Boulet S, Bruneau J, Tremblay CL, Bernard NF; investigators of the Canadian Cohort of HIV Infected Slow Progressors.

Clin Immunol. 2012 Jun;143(3):246-55. doi: 10.1016/j.clim.2012.01.001. Epub 2012 Jan 15.

PMID:
22445844
33.

HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.

Parsons MS, Wren L, Isitman G, Navis M, Stratov I, Bernard NF, Kent SJ.

J Virol. 2012 Apr;86(8):4488-95. doi: 10.1128/JVI.06112-11. Epub 2012 Feb 15.

34.

Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection.

Wang C, McPherson AJ, Jones RB, Kawamura KS, Lin GH, Lang PA, Ambagala T, Pellegrini M, Calzascia T, Aidarus N, Elford AR, Yue FY, Kremmer E, Kovacs CM, Benko E, Tremblay C, Routy JP, Bernard NF, Ostrowski MA, Ohashi PS, Watts TH.

J Exp Med. 2012 Jan 16;209(1):77-91. doi: 10.1084/jem.20110675. Epub 2011 Dec 19.

35.

T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers.

Kamya P, Tsoukas CM, Boulet S, Routy JP, Thomas R, Côté P, Boulassel MR, Lessard B, Kaul R, Ostrowski M, Kovacs C, Tremblay CL, Bernard NF.

AIDS Res Ther. 2011 Jun 16;8(1):20. doi: 10.1186/1742-6405-8-20.

36.

Relative contribution of HIV-specific functional lymphocyte subsets restricted by protective and non-protective HLA alleles.

Peretz Y, Marra O, Thomas R, Legault D, Côté P, Boulassel MR, Rouleau D, Routy JP, Sékaly RP, Tsoukas CM, Tremblay C, Bernard NF.

Viral Immunol. 2011 Jun;24(3):189-98. doi: 10.1089/vim.2010.0117.

PMID:
21668360
37.

Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire.

Parsons MS, Rouleau D, Routy JP, LeBlanc R, Grant MD, Bernard NF.

AIDS. 2011 Jun 19;25(10):1249-64. doi: 10.1097/QAD.0b013e328347f9fa.

PMID:
21516028
38.

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.

International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G Jr, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC Jr, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL Jr, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC 3rd, Olender SA, Ostrowski M, Owen WF Jr, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC 3rd, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM Jr, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M.

Science. 2010 Dec 10;330(6010):1551-7. doi: 10.1126/science.1195271. Epub 2010 Nov 4.

39.

Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection.

Parsons MS, Boulet S, Song R, Bruneau J, Shoukry NH, Routy JP, Tsoukas CM, Bernard NF.

J Infect Dis. 2010 Nov 1;202 Suppl 3:S356-60. doi: 10.1086/655966.

PMID:
20887224
40.

Changes in function of HIV-specific T-cell responses with increasing time from infection.

Ndongala ML, Kamya P, Boulet S, Peretz Y, Rouleau D, Tremblay C, Leblanc R, Côté P, Baril JG, Thomas R, Vézina S, Boulassel MR, Routy JP, Sékaly RP, Bernard NF.

Viral Immunol. 2010 Apr;23(2):159-68. doi: 10.1089/vim.2009.0084.

41.

Dual-color ELISPOT assay for the simultaneous detection of IL-2 and/or IFN-gamma secreting T cells.

Boulet S, Ndongala ML, Bernard NF.

Cold Spring Harb Protoc. 2010 Jan;2010(1):pdb.prot5369. doi: 10.1101/pdb.prot5369. No abstract available.

PMID:
20150128
42.

HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells.

Boulet S, Song R, Kamya P, Bruneau J, Shoukry NH, Tsoukas CM, Bernard NF.

J Immunol. 2010 Feb 15;184(4):2057-64. doi: 10.4049/jimmunol.0902621. Epub 2010 Jan 8.

43.

Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.

Huang KH, Loutfy MR, Boulet S, Toma E, Tsoukas CM, Bernard NF.

Antivir Ther. 2009;14(3):381-92.

PMID:
19474472
44.

HIV Gag p24 specific responses secreting IFN-gamma and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load.

Ndongala ML, Peretz Y, Boulet S, Doroudchi M, Yassine-Diab B, Boulassel MR, Rouleau D, Tremblay C, LeBlanc R, Routy JP, Sékaly RP, Bernard NF.

Clin Immunol. 2009 May;131(2):277-87. doi: 10.1016/j.clim.2008.11.006. Epub 2009 Jan 8.

PMID:
19135418
45.

[Carrying certain KIR3DL1 alleles with HLA-B*57 is associated with protection from HIV infection].

Boulet S, Bernard NF.

Med Sci (Paris). 2008 Dec;24(12):1030-2. doi: 10.1051/medsci/200824121030. French. No abstract available.

46.

A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.

Boulet S, Kleyman M, Kim JY, Kamya P, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF.

AIDS. 2008 Jul 31;22(12):1487-91. doi: 10.1097/QAD.0b013e3282ffde7e.

PMID:
18614872
47.

HIV Gag-specific immune responses predict the rate of CD4 decline.

Peretz Y, Tsoukas CM, Bernard NF.

AIDS. 2008 Jun 19;22(10):1222-4. doi: 10.1097/QAD.0b013e3283021a76.

PMID:
18525269
48.

Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption.

Huang KH, Loutfy MR, Tsoukas CM, Bernard NF.

BMC Infect Dis. 2008 May 2;8:59. doi: 10.1186/1471-2334-8-59.

49.

Spontaneous resolution of hepatitis C virus infection is not due to a mutation at Cys-508 of MAVS/VISA/IPS-1/CARDIF.

Huang KH, Bruneau J, Shoukry N, Bernard NF.

J Clin Virol. 2008 Jun;42(2):229-30. doi: 10.1016/j.jcv.2008.01.010. Epub 2008 Mar 11. No abstract available.

PMID:
18337166
50.

Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals.

Boulet S, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF.

AIDS. 2008 Mar 12;22(5):595-9. doi: 10.1097/QAD.0b013e3282f56b23.

PMID:
18317000

Supplemental Content

Loading ...
Support Center